Ligne de temps

Fernando Batista
Post-doctorant(e)
05 avr. 2024
publication

Insights from structure-activity relationships and the binding mode of peptidic α-ketoamide inhibitors of the malaria drug target subtilisin-like SUB1.

Lire plus
15 juil. 2022
publication

Thiosulfate sulfurtransferase prevents hyperglycemic damage to the zebrafish pronephros in an experimental model for diabetes.

Lire plus
01 août 2021
publication

Clinical utility of the imunohistochemical co-expression of p53 and MDM2 in thyroid follicular lesions.

Lire plus
09 sept. 2020
publication

Polymorphisms of IL-4 and IL-4R are associated to some demographic characteristics of differentiated thyroid cancer patients but are not determinants of risk in the Brazilian population.

Lire plus
01 juin 2020
publication

Unraveling the role of thiosulfate sulfurtransferase in metabolic diseases.

Lire plus
08 mai 2020
publication

Molecular Target Validation of Aspartate Transcarbamoylase from Plasmodium falciparum by Torin 2.

Lire plus
01 mars 2020
publication

A novel mechanism of inhibition by phenylthiourea on PvdP, a tyrosinase synthesizing pyoverdine of Pseudomonas aeruginosa.

Lire plus
01 févr. 2020
publication

New directions in antimalarial target validation.

Lire plus
28 févr. 2019
publication

Oligomeric protein interference validates druggability of aspartate interconversion in Plasmodium falciparum.

Lire plus
11 mars 2018
publication

Identification of a non-competitive inhibitor of Plasmodium falciparum aspartate transcarbamoylase.

Lire plus
01 févr. 2018
publication

Serum interleukin measurement may help identify thyroid cancer patients with active disease.

Lire plus
01 janv. 2018
publication

Oligomeric interfaces as a tool in drug discovery: Specific interference with activity of malate dehydrogenase of Plasmodium falciparum in vitro.

Lire plus
12 déc. 2017
publication

Tyrosine kinase inhibitor sensitive PDGFRΑ mutations in GIST: Two cases and review of the literature.

Lire plus
01 janv. 2017
publication

Drug Target Validation Methods in Malaria – Protein Interference Assay (PIA) as a Tool for Highly Specific Drug Target Validation.

Lire plus
01 juil. 2016
publication

Crystal structure of truncated aspartate transcarbamoylase from Plasmodium falciparum.

Lire plus
01 avr. 2016
publication

Gene expression of thyroid-specific transcription factors may help diagnose thyroid lesions but are not determinants of tumor progression.

Lire plus
01 févr. 2016
team

Biologie moléculaire des Trypanosomes

Lire plus
01 oct. 2014
publication

Obesity and thyroid cancer.

Lire plus
01 janv. 2014
publication

CD8+ TIL recruitment may revert the association of MAGE A3 with aggressive features in thyroid tumors.

Lire plus